1-4 of 4
Sheh-Li Chen, PharmD
Close
Sort by
Journal Articles

Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Anqi Zhu, MS, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 390.
https://doi.org/10.1182/blood-2019-121343
Published: 2019
Journal Articles

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 792.
https://doi.org/10.1182/blood-2019-121340
Published: 2019
Journal Articles

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Nigel S. Key, MBChB, FRCP, Raj S. Kasthuri, MD, Micah J. Mooberry, MD, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2474.
https://doi.org/10.1182/blood-2018-99-118839
Published: 2018
Journal Articles

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1202.
https://doi.org/10.1182/blood-2018-99-119196
Published: 2018